Amylyx Pharmaceuticals, Inc. (AMLX) Reports In-Line Q2 EPS

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q2 EPS of ($0.46), in-line with the analyst estimate of ($0.46).

For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.

You May Also Be Interested In

• Trump: Iran Will Pay For US Forces Killings Many Times Over
• MainStreet Bancshares, Inc. (MNSB) Tops Q2 EPS by 5c
• Jordan Says Intercepted Three Missiles Coming From Iran: Petra - Bloomberg